Published in Cancer Weekly, September 16th, 2003
According to a study from Germany, "Despite recent advances in techniques of in situ tumor ablation, surgical therapy remains at present the mainstay treatment for primary hepatic malignancies.
"After an initial endeavor in the establishment of liver transplantation as a treatment option, in particular for unresectable liver tumors, only a few indications, for example early hepatocellular carcinoma in cirrhosis, are currently agreed upon," wrote T. Steinmuller and colleagues, Campus Virchow Klinikum, Department of Visceral & Transplantation Surgery.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-09-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.